glp-1 agonists and muscle loss Comment “Curious” for the deep dive 👇 A new 2026 study suggests we might have been totally wrong about GLP-1s mass loss. These data suggest receptor may not Weight loss: Study finds keys

The "it clogs your pores" myth has been around for decades

Nobody knows how often adverse events occur, said Kristen Nixon, a Johns Hopkins University researcher who has studied posts about weight loss drugs on Reddit, a popular online forum

Wang L, Yang G, Zhao D, Wang J, Bai Y, Peng Q, et al

Ipamorelin's human data is limited to two published pharmacokinetic/pharmacodynamic studies: a 1999 PK/PD study (PMID: 10496658) that documented dose-response relationships and peak GH at 30-40 minutes post-injection in human volunteers, and a completed Phase II clinical trial for postoperative ileus (NCT00672074), after which ipamorelin's development for this indication was discontinued without approval